November 25, 2016
Shionogi Pres. Teshirogi (second right), Tokushima University Officials at Osaka Press Conference Shionogi said on November 24 that it has clinched a pact to license a novel type A2 Botulinum toxin candidate A2NTX from Tokushima University, planning to globally develop...read more